HELP ▼ -26.5% - Helus Pharma Inc
$HELP - Helus Pharma Announces Positive Topline Results from Phase 3 APPROACH Study evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder
16-NOV-2026 07:00 AM ET
Share this post
More filings for $HELP
HELP ▲ +18.3% - Helus Pharma IncNov 16, 2026HELP ▲ +3.2% - Helus Pharma IncNov 15, 2026HELP ▲ +2.2% - Cybin D/B/A Helus PharmaNov 3, 2026HELP ▲ +0.1% - Cybin D/B/A Helus PharmaOct 27, 2026HELP ▼ -2.7% - Cybin D/B/A Helus PharmaOct 21, 2026HELP ▼ -0.2% - Cybin D/B/A Helus PharmaOct 15, 2026
View full $HELP filing history →💬 Comments
Loading comments…
Leave a comment
